Australia Self-Monitoring Blood Glucose Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Australia Self-Monitoring Blood Glucose Market is Segmented Into Components (Glucometer Devices, Test Strips, Lancets). The Report Offers the Value (in USD Million) and Volume (in Units Million) for the Above Segments.

Australia Self-Monitoring Blood Glucose Market Size and Share

Australia Self-Monitoring Blood Glucose Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Australia Self-Monitoring Blood Glucose Market Analysis by Mordor Intelligence

The Australia Self-Monitoring Blood Glucose Market size was valued at USD 219.99 million in 2026 and is estimated to grow from USD 232.09 million in 2027 to reach USD 303.33 million by 2032, at a CAGR of 5.5% during the forecast period (2027-2032).

During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, metabolic comorbidities, and more severe illness from SARS-CoV-2 infection. According to the Australian Bureau of Statistics, COVID-19 data from January 2020 to March 2022, pre-existing chronic conditions such as diabetes were reported on death certificates for 3,600 (73%) of the 4,900 deaths due to COVID-19. Diabetes was a pre-existing condition in 20% of the 3,600 deaths. Maintaining euglycemia was important to decrease morbidity and mortality in the hospital setting. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe and improved inpatient glycemic outcomes and played a vital role in managing hypoglycemia and hyperglycemia in hospitalized patients.

Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. The measurement of blood glucose helps determine the effectiveness of blood glucose metabolism and guides in achieving optimal glucose control within the body. Over time the readings provide the patient and their health professionals with the information required to determine the best management strategy for diabetes. Appropriate and timely blood glucose monitoring allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.

Technological advancements in blood glucose meters, including cellular-connected devices that automatically upload SMBG data to secure cloud-based databases, allow for improved sharing and monitoring of SMBG data. Real-time monitoring of SMBG data presents opportunities to provide timely support to patients responsive to abnormal SMBG recordings. Such advantages can provide patients with poorly controlled T2D additional support needed to improve critical outcomes, thereby enhancing the market prospects in future years.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Competitive Landscape

The Australia Self-Monitoring Blood Glucose Market is moderately fragmented, with few significant and other generic players. Manufacturers like Abbott, LifeScan, F. Hoffmann-La Roche AG, and Ascensia occupy a major share.

Australia Self-Monitoring Blood Glucose Industry Leaders

  1. Roche Diabetes Care

  2. Abbott Diabetes Care

  3. LifeScan

  4. Arkray, Inc.

  5. Ascensia Diabetes Care

  6. *Disclaimer: Major Players sorted in no particular order
Australia Self-Monitoring Blood Glucose Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes - one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
  • February 2022: Zurich Australia launched an Australian-first pilot of a new mobile health app that enables life insurance customers with diabetes to monitor their blood sugar levels and self-manage their diabetes. Pops is a first-of-its-kind integrated health management system with a simple glucose meter attached to a smartphone. Paired with the Pops app and AI health coach, it wirelessly records blood sugar results, making it one of the most discreet and easy-to-use diabetes self-management tools available.

Table of Contents for Australia Self-Monitoring Blood Glucose Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Component (Value and Volume, 2017 - 2028)
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population (2017 - 2028)
  • 6.2 Type-2 Diabetes population (2017 - 2028)

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Holding AG
    • 7.1.3 LifeScan
    • 7.1.4 Trividia Health
    • 7.1.5 Ascensia Diabetes Care
    • 7.1.6 Acon Laboratories Inc.
    • 7.1.7 Agamatrix Inc.
    • 7.1.8 Bionime Corporation
    • 7.1.9 Arkray Inc.
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Abbott Diabetes Care
    • 7.2.2 Roche Holding AG
    • 7.2.3 LifeScan
    • 7.2.4 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Australia Self-Monitoring Blood Glucose Market Report Scope

Self-monitoring of blood glucose is used by diabetic patients to measure their blood sugar level using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The Australia Self-Monitoring Blood Glucose Market is segmented into Components (Glucometer Devices, Test Strips, Lancets). The Australia Self-Monitoring Blood Glucose Market is segmented into components (Glucometer Devices, Test Strips, Lancets). The report offers the value (in USD million) and volume (in Units million) for the above segments.

Component (Value and Volume, 2017 - 2028)
Australia Self-Monitoring Blood Glucose Market segmentation breakdown
Glucometer Devices
Test Strips
Lancets
Australia Self-Monitoring Blood Glucose Market segmentation breakdown
Component (Value and Volume, 2017 - 2028) Glucometer Devices
Test Strips
Lancets

Key Questions Answered in the Report

How big is the Australia Self-Monitoring Blood Glucose Market is expected to grow by 2032?

The Australia Self-Monitoring Blood Glucose Market size is expected to reach USD 303.33 million by 2032.

What is the current Australia Self-Monitoring Blood Glucose Market size?

In 2026, the Australia Self-Monitoring Blood Glucose Market size reached USD 219.99 Mn.

Who are the key players in Australia Self-Monitoring Blood Glucose Market?

Roche Diabetes Care, Abbott Diabetes Care, LifeScan, Arkray, Inc. and Ascensia Diabetes Care are the major companies operating in the Australia Self-Monitoring Blood Glucose Market.

Which component is expanding fastest?

Glucometer devices are growing at the fastest pace, driven by broader reimbursement coverage and declining prices.

Page last updated on:

Australia Self-Monitoring Blood Glucose Market Report Snapshots